Effect of Bias in Contrast Agent Concentration Measurement on Estimated Pharmacokinetic Parameters in Brain Dynamic Contrast-Enhanced Magnetic Resonance Imaging Studies
author
Abstract:
Introduction: Pharmacokinetic (PK) modeling of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is widely applied in tumor diagnosis and treatment evaluation. Precision analysis of the estimated PK parameters is essential when they are used as a measure for therapy evaluation or treatment planning. In this study, the accuracy of PK parameters in brain DCE-MRI studies was quantified in relation to two major sources of error(including pre-contrast longitudinal-relaxation time, T1,0 and flip angle, α). Material and Methods: 3470 dynamic contrast-enhanced-curves were simulated using a wide variation of the PK parameters. The bias of contrast concentration due to the systematic biases in α and T1,0 was calculated and added to both contrast concentration and AIF profiles. Thereafter, the PK parameters were estimated for each simulated curve in the presence of different percentages of relative biases in α and T1,0. The mean percentage error (MPE) of PK parameters was then calculated for all simulated curves. Results: The results indicated that plasma volume(vp) was the most sensitive parameter to bias of contrast concentration, which may overestimate up to 700% in 10% coincidence relative bias in α and T1,0. The lowest MPE was related to the backward transfer constant (kep), which was ~2%-15% in 10% coincidence relative bias in each α and T1, 0. Conclusion: Utilization of a nested model selection technique, along with an accurate estimator, such as maximum-likelihood estimation, created a unique approach for investigating the effect of the bias in the concentration measurement to the estimated PK parameters without the addition of any extra biases to the parameters during the estimation.
similar resources
contrast enhanced magnetic resonance imaging in sacroiliitis
conclusion fs t2 w and ce fs t1 w sequences of axial planes were the most useful sequences in determination of active sacroiliitis. therefore, in patients with renal failure or allergy to contrast media, fs t2 wi can be obtained to detect active sacroiliitis. objectives the aim of this retrospective study was to assess the value of different magnetic resonance imaging (mri) sequences in evaluat...
full textContrast agents in dynamic contrast-enhanced magnetic resonance imaging
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a noninvasive method to assess angiogenesis, which is widely used in clinical applications including diagnosis, monitoring therapy response and prognosis estimation in cancer patients. Contrast agents play a crucial role in DCE-MRI and should be carefully selected in order to improve accuracy in DCE-MRI examination. Over the past...
full textdiagnostic accuracy of dynamic contrast enhanced magnetic resonance imaging in characterizing lung masses
background imaging plays a critical role not only in the detection, but also in the characterization of lung masses as benign or malignant. objectives to determine the diagnostic accuracy of dynamic magnetic resonance imaging (mri) in the differential diagnosis of benign and malignant lung masses. patients and methods ninety-four masses were included in this prospective study. five dynamic seri...
full textDynamic contrast enhanced magnetic resonance imaging in chronic Achilles tendinosis
BACKGROUND Chronic Achilles tendinosis is a common problem. When evaluating and comparing different therapies there is a need for reliable imaging methods. Our aim was to evaluate if chronic Achilles tendinosis affects the dynamic contrast-enhancement in the tendon and its surroundings and if short-term eccentric calf-muscle training normalizes the dynamic contrast-enhancement. METHODS 20 pat...
full textDynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is being used in oncology as a noninvasive method for measuring properties of the tumor microvasculature. There is potential for DCE-MRI to be used as an imaging biomarker to measure antiangiogenic effects of cancer treatments. This article reviews the general methodology for performing DCE-MRI and discusses existing data and challe...
full textMy Resources
Journal title
volume 17 issue 3
pages 142- 152
publication date 2020-05-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023